Patients with diabetes mellitus (DM) have accelerated atherosclerosis with an increased risk for atherothrombotic cardiovascular complications. A state of high platelet reactivity and activation, hypercoagulability (prothrombotic state) and a subdued response to standard antiplatelet agents may explain high rate of adverse cardiovascular events in patients with DM. Several antithrombotic treatment strategies have been developed to control the prothrombotic state in patients with DM: dose modification of commonly used agents; use of potent agents; and addition of a third antithrombotic drug (triple therapy) to commonly prescribed dual antiplatelet therapy of aspirin and a P2Y₁₂ inhibitor. The present review aims to provide an overview of the current knowledge on platelet abnormalities in patients with DM, focusing on the challenges and perspectives of antiplatelet treatment strategies in this population.

Citations

Citations to this article as recorded by  

• Mice expressing nonpolymerizable fibrinogen have reduced arterial and venous thrombosis with preserved hemostasis
  Woosuk S. Hur, Tomohiro Kawano, Jean Marie N. Mwiza, David S. Paul, Robert H. Lee, Emily G. Clark, Emma G. Bouck, Ananya Dutta, Can Cai, Stephen R. Baker, Martin Guthold, Nigel Mackman, Pierre Mangin, Alisa S. Wolberg, Wolfgang Bergmeier, Matthew J. Flick
  Blood.2024; 143(2): 105.     CrossRef
• On‐Treatment Platelet Reactivity and Ischemic Outcomes in Patients With Diabetes Mellitus: Two‐Year Results From ADAPT‐DES
  Bahira Shahim, Björn Redfors, Thomas D. Stuckey, Mengdan Liu, Zhipeng Zhou, Bernhard Witzenbichler, Giora Weisz, Michael J. Rinaldi, Franz‐Josef Neumann, D. Christopher Metzger, Timothy D. Henry, David A. Cox, Peter L. Duffy, Bruce R. Brodie, Iva Srdanovi
  Journal of the American Heart Association.2023;[Epub]     CrossRef
• Platelet Glycoprotein-Ib (GPIb) May Serve as a Bridge between Type 2 Diabetes Mellitus (T2DM) and Atherosclerosis, Making It a Potential Target for Antiplatelet Agents in T2DM Patients
  Muttia Amalia, Meidi Utami Puteri, Fadlina Chany Saputri, Rani Sauriasari, Bambang Widyantoro
  Life.2023; 13(7): 1473.     CrossRef
• Polymorphisms of genes related to phase II metabolism and resistance to clopidogrel
  Abdullah Alkattan, Ahmed Alkhalifah, Eman Alsalameen, Fatimah Alghanim, Nashwa Radwan
  Pharmacogenomics.2022; 23(1): 61.     CrossRef
• Prolonged dual antiplatelet therapy after drug-eluting stent implantation in patients with diabetes mellitus: A nationwide retrospective cohort study
  Seung-Jun Lee, Dong-Woo Choi, Choongki Kim, Yongsung Suh, Sung-Jin Hong, Chul-Min Ahn, Jung-Sun Kim, Byeong-Keuk Kim, Young-Guk Ko, Donghoon Choi, Eun-Cheol Park, Yangsoo Jang, Chung-Mo Nam, Myeong-Ki Hong
  Frontiers in Cardiovascular Medicine.2022;[Epub]     CrossRef
• New opportunities of antithrombotic therapy in patients with type 2 diabetes mellitus and stable coronary heart disease for reducing the cardiovascular risk and cardiovascular complications: THEMIS, THEMIS-PCI trials
  Victor I. Kalashnikov, Marina S. Michurova
  Terapevticheskii arkhiv.2022; 94(10): 1204.     CrossRef
• Ischemic and Bleeding Events of Ticagrelor Monotherapy in Korean Patients With and Without Diabetes Mellitus: Insights From the TICO Trial
  Kyeong Ho Yun, Jae Young Cho, Seung Yul Lee, Sang Jae Rhee, Byeong Keuk Kim, Myeong Ki Hong, Yangsoo Jang, Seok Kyu Oh
  Frontiers in Pharmacology.2021;[Epub]     CrossRef
• Long-term outcomes of ischaemic stroke patients with diabetes in a multi-ethnic cohort in Singapore
  Ei Zune The, Mei Yen Ng, Geelyn JL Ng, Bernadette GC Er, Amy ML Quek, Prakash Paliwal, Leonard L Yeo, Bernard PL Chan, Vijay K Sharma, Hock Luen Teoh, Eric YH Khoo, Raymond CS Seet
  Annals of the Academy of Medicine, Singapore.2021; 50(1): 16.     CrossRef
• Protective Role of Platelets in Myocardial Infarction and Ischemia/Reperfusion Injury
  Kornela Hałucha, Alina Rak-Pasikowska, Iwona Bil-Lula, David J. Chambers
  Cardiology Research and Practice.2021; 2021: 1.     CrossRef
• Pre- and Post-Conditioning of the Heart: An Overview of Cardioprotective Signaling Pathways
  Denise Coutinho de Miranda, Gabriela de Oliveira Faria, Milla Marques Hermidorff, Fernanda Cacilda dos Santos Silva, Leonardo Vinícius Monteiro de Assis, Mauro César Isoldi
  Current Vascular Pharmacology.2021; 19(5): 499.     CrossRef
• Post-Transcriptional Expression Control in Platelet Biogenesis and Function
  Carolin T. Neu, Tony Gutschner, Monika Haemmerle
  International Journal of Molecular Sciences.2020; 21(20): 7614.     CrossRef
• The impact of metformin and aspirin on T-cell mediated inflammation: A systematic review of in vitro and in vivo findings
  Tawanda Maurice Nyambuya, Phiwayinkosi Vusi Dludla, Vuyolwethu Mxinwa, Kabelo Mokgalaboni, Siphamandla Raphael Ngcobo, Luca Tiano, Bongani Brian Nkambule
  Life Sciences.2020; 255: 117854.     CrossRef
• Short- versus long-term dual antiplatelet therapy after second-generation drug-eluting stent implantation in patients with diabetes mellitus: A meta-analysis of randomized controlled trials
  Hongyu Zhang, Junsong Ke, Jun Huang, Kai Xu, Yun Chen, Timir Paul
  PLOS ONE.2020; 15(12): e0242845.     CrossRef
• Long non-coding RNA metallothionein 1 pseudogene 3 promotes p2y12 expression by sponging miR-126 to activate platelet in diabetic animal model
  Ming Zhou, Meng Gao, Yanwei Luo, Rong Gui, Hongwen Ji
  Platelets.2019; 30(4): 452.     CrossRef
• Circulating blood cells and extracellular vesicles in acute cardioprotection
  Sean M Davidson, Ioanna Andreadou, Lucio Barile, Yochai Birnbaum, Hector A Cabrera-Fuentes, Michael V Cohen, James M Downey, Henrique Girao, Pasquale Pagliaro, Claudia Penna, John Pernow, Klaus T Preissner, Péter Ferdinandy
  Cardiovascular Research.2019; 115(7): 1156.     CrossRef
• Comparison of 1-year clinical outcomes between prasugrel and ticagrelor versus clopidogrel in type 2 diabetes patients with acute myocardial infarction underwent successful percutaneous coronary intervention
  Kye Taek Ahn, Seok-Woo Seong, Ung Lim Choi, Seon-Ah Jin, Jun Hyung Kim, Jae-Hwan Lee, Si Wan Choi, Myung Ho Jeong, Shung Chull Chae, Young Jo Kim, Chong Jin Kim, Hyo-Soo Kim, Myeong-Chan Cho, Hyeon-Cheol Gwon, Jin-Ok Jeong, In-Whan Seong
  Medicine.2019; 98(11): e14833.     CrossRef
• Fibrin Clot Strength in Patients with Diabetes Mellitus Measured by Thrombelastography
  Benjamin T. Maatman, Glen Schmeisser, Rolf P. Kreutz
  Journal of Diabetes Research.2018; 2018: 1.     CrossRef
• Role of proprotein convertase subtilisin/kexin type 9 inhibitors in patients with coronary artery disease undergoing percutaneous coronary intervention
  Eliano P. Navarese, Michalina Kołodziejczak, Aniela Petrescu, Bernhard Wernly, Michael Lichtenauer, Alexander Lauten, Antonino Buffon, Wojciech Wanha, Vincenzo Pestrichella, Gennaro Sardella, Gaetano Contegiacomo, Udaya Tantry, Kevin Bliden, Jacek Kubica,
  Expert Review of Cardiovascular Therapy.2018; 16(6): 419.     CrossRef
• Cardioprotective Properties of Human Platelets Are Lost in Uncontrolled Diabetes Mellitus: A Study in Isolated Rat Hearts
  Isabella Russo, Saveria Femminò, Cristina Barale, Francesca Tullio, Stefano Geuna, Franco Cavalot, Pasquale Pagliaro, Claudia Penna
  Frontiers in Physiology.2018;[Epub]     CrossRef
• Aortic thrombosis in dogs
  Trevor P.E. Williams, Scott Shaw, Adam Porter, Larry Berkwitt
  Journal of Veterinary Emergency and Critical Care.2017; 27(1): 9.     CrossRef
• Challenges in Patients with Diabetes: Improving Clinical Outcomes After Percutaneous Coronary Intervention Through EVOlving Stent Technology
  Robert A Byrne, Shmuel Banai, Roisin Colleran, Antonio Colombo
  Interventional Cardiology Review.2017; 13(01): 40.     CrossRef
• Adding CABG to the Dual Antiplatelet Salad
  Glenn N. Levine, Faisal G. Bakaeen
  Journal of the American College of Cardiology.2017; 69(2): 128.     CrossRef
• The association between arterial stiffness and tongue manifestations of blood stasis in patients with type 2 diabetes
  Po-Chi Hsu, Yu-Chuen Huang, John Y. Chiang, Hen-Hong Chang, Pei-Yung Liao, Lun-Chien Lo
  BMC Complementary and Alternative Medicine.2016;[Epub]     CrossRef
• Platelet phenotype changes associated with breast cancer and its treatment
  Chris E. Holmes, Jamie E. Levis, David J. Schneider, Nadia M. Bambace, Deva Sharma, Inder Lal, Marie E. Wood, Hyman B. Muss
  Platelets.2016; 27(7): 703.     CrossRef

Atherothrombotic complications are important causes of morbidity and mortality in diabetic patients. Diabetes has been considered to be a prothrombotic status. Several factors contribute to the prothrombotic condition, such as increasing coagulation, impaired fibrinolysis, endothelial dysfunction, and platelet hyperreactivity. Among the factors that contribute to the prothrombotic status in diabetes, altered platelet function plays a crucial role. Although understanding platelet function abnormalities in diabetes still remains as a challenge, more attention should be focused on platelet function for effective management and the prediction of atherothrombotic events in diabetic patients. This review will provide an overview on the current status of knowledge of platelet function abnormalities and clinical marker of platelet hyperreactivity in patients with diabetes.

Citations

Citations to this article as recorded by  

• Prediction of type 2 diabetes mellitus using hematological factors based on machine learning approaches: a cohort study analysis
  Amin Mansoori, Toktam Sahranavard, Zeinab Sadat Hosseini, Sara Saffar Soflaei, Negar Emrani, Eisa Nazar, Melika Gharizadeh, Zahra Khorasanchi, Sohrab Effati, Mark Ghamsary, Gordon Ferns, Habibollah Esmaily, Majid Ghayour Mobarhan
  Scientific Reports.2023;[Epub]     CrossRef
• Platelet P2Y1 receptor exhibits constitutive G protein signaling and β-arrestin 2 recruitment
  Agnès Ribes, Cédric Garcia, Marie-Pierre Gratacap, Evi Kostenis, Laurent O. Martinez, Bernard Payrastre, Jean-Michel Sénard, Céline Galés, Véronique Pons
  BMC Biology.2023;[Epub]     CrossRef
• Sex differences in the relationship between platelet count and type 2 diabetes risk in community‐dwelling adults: Longitudinal findings over 14 years
  Eun Kyeong Yun, In‐Ho Seo, Hye Sun Lee, So‐Young Seol, Yong‐Jae Lee
  Diabetes/Metabolism Research and Reviews.2023;[Epub]     CrossRef
• Platelet Glycoprotein-Ib (GPIb) May Serve as a Bridge between Type 2 Diabetes Mellitus (T2DM) and Atherosclerosis, Making It a Potential Target for Antiplatelet Agents in T2DM Patients
  Muttia Amalia, Meidi Utami Puteri, Fadlina Chany Saputri, Rani Sauriasari, Bambang Widyantoro
  Life.2023; 13(7): 1473.     CrossRef
• Effect of oral versus parenteral vitamin D3 supplementation on nuclear factor-κB and platelet aggregation in type 2 diabetic patients
  Esraa Habiba, Samia Ali, Yehia Ghanem, Ola Sharaki, Wafaa Hewedy
  Canadian Journal of Physiology and Pharmacology.2023; 101(11): 610.     CrossRef
• Characteristics of cerebral ischemic stroke based on moyamoya disease and atherosclerosis-associated intracranial arterial stenosis
  Zhiying Chen, Xiaoqin Wu, Da Zhou, Shuling Shang, Yuchuan Ding, Xunming Ji, Ran Meng
  Neurological Sciences.2022; 43(2): 1087.     CrossRef
• Basic Coagulation Profiles and Platelet Parameters Among Adult Type 1 and Type 2 Diabetes Patients at Dessie Referral Hospital, Northeast Ethiopia: Comparative Cross-Sectional Study
  Hussen Ebrahim, Fikir Asrie, Zegeye Getaneh
  Journal of Blood Medicine.2021; Volume 12: 33.     CrossRef
• Magnetic fields as a potential therapy for diabetic wounds based on animal experiments and clinical trials
  Huanhuan Lv, Junyu Liu, Chenxiao Zhen, Yijia Wang, Yunpeng Wei, Weihao Ren, Peng Shang
  Cell Proliferation.2021;[Epub]     CrossRef
• Diabetes and hypertension: Pivotal involvement of purinergic signaling
  Karine Paula Reichert, Milagros Fanny Vera Castro, Charles Elias Assmann, Nathieli Bianchin Bottari, Vanessa Valéria Miron, Andréia Cardoso, Naiara Stefanello, Vera Maria Melchiors Morsch, Maria Rosa Chitolina Schetinger
  Biomedicine & Pharmacotherapy.2021; 137: 111273.     CrossRef
• The hemostatic parameters in pregnant women with different types of diabetes mellitus
  R. V. Kapustin, E. V. Kopteeva, O. N. Arzhanova, A. V. Tiselko, N. Е. Androsova, T. I. Oparina
  Diabetes mellitus.2021; 24(3): 251.     CrossRef
• Comparison of the progressive changes in hemogram parameters of normal glycemic and gestational diabetic patients throughout the first two trimesters and predictive ability of these indices for gestational diabetes mellitus
  Pelin AYTAN, Seyran BOZKURT BABUŞ, Özde SAKARYA, Revan Sabri ÇİFTÇİ, Kasım AKAY, Hakan AYTAN
  Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi.2020; 17(4): 533.     CrossRef
• A Pilot Study on the Effect of Anti-Thrombopoietin Antibody on Platelet Count in Patients with Type 2 Diabetes
  Takuya Fukuda, Masahide Hamaguchi, Takafumi Osaka, Yoshitaka Hashimoto, Emi Ushigome, Mai Asano, Masahiro Yamazaki, Eriko Fukuda, Kei Yamaguchi, Koji Ogawa, Naoki Goshima, Michiaki Fukui
  Molecules.2020; 25(7): 1667.     CrossRef
• Patient with diabetes after acute coronary event. How to improve forecast?
  O. L. Barbarash
  Medical alphabet.2019; 1(3): 6.     CrossRef
• Enhanced Platelet Sensitivity to IGF-1 in Patients with Type 2 Diabetes Mellitus
  N. Gligorijevic, D. Robajac, O. Nedic
  Biochemistry (Moscow).2019; 84(10): 1213.     CrossRef
• Comprehensive Quality Control of the Regenerative Therapy Using Platelet Concentrates: The Current Situation and Prospects in Japan
  Tomoyuki Kawase, Kazuhiro Okuda
  BioMed Research International.2018; 2018: 1.     CrossRef
• Changes in platelet morphology indices in relation to duration of disease and glycemic control in children with type 1 diabetes mellitus
  Vybhav Venkatesh, Rakesh Kumar, Dinesh Kumar Varma, Prateek Bhatia, Jaivinder Yadav, Devi Dayal
  Journal of Diabetes and its Complications.2018; 32(9): 833.     CrossRef
• Quantifying Platelet Margination in Diabetic Blood Flow
  Hung-Yu Chang, Alireza Yazdani, Xuejin Li, Konstantinos A.A. Douglas, Christos S. Mantzoros, George Em Karniadakis
  Biophysical Journal.2018; 115(7): 1371.     CrossRef
• Redox Proteomics and Platelet Activation: Understanding the Redox Proteome to Improve Platelet Quality for Transfusion
  Giona Sonego, Mélanie Abonnenc, Jean-Daniel Tissot, Michel Prudent, Niels Lion
  International Journal of Molecular Sciences.2017; 18(2): 387.     CrossRef
• Farnesoid X Receptor and Liver X Receptor Ligands Initiate Formation of Coated Platelets
  Amanda J. Unsworth, Alexander P. Bye, Dionne S. Tannetta, Michael J.R. Desborough, Neline Kriek, Tanya Sage, Harriet E. Allan, Marilena Crescente, Parveen Yaqoob, Timothy D. Warner, Chris I. Jones, Jonathan M. Gibbins
  Arteriosclerosis, Thrombosis, and Vascular Biology.2017; 37(8): 1482.     CrossRef
• Aspirin in the prevention of cardiovascular events in patients with diabetes
  David S. H. Bell
  Postgraduate Medicine.2016; 128(2): 180.     CrossRef
• ROLE OF NITRIC OXIDE METABOLITES WITHIN THE IMPACT OF THE SUB-TOXIC SUCCINAMIDES DOSES ON STATE OF HEMOSTASIS
  I.А. Palagina, M.Y. Kudria, О.S. Lаlymеnkо
  Fiziolohichnyĭ zhurnal.2016; 62(6): 34.     CrossRef
• Influence of genetic variations in platelet glycoproteins and eNOS in the development of arterial ischaemia of lower limbs in type 2 diabetes mellitus patients
  Virginia Carvalhais, Ema Ruivães, Luis Bernardo Pina-Cabral, Bárbara Mesquita, Flávio Oliveira, Maria Céu Monteiro, Maria Begoña Criado
  The Foot.2016; 29: 42.     CrossRef
• Circulating endothelial progenitor cells and angiogenic factors in diabetes complicated diabetic foot and without foot complications
  Arleta Kulwas, Ewelina Drela, Wiesław Jundziłł, Barbara Góralczyk, Barbara Ruszkowska-Ciastek, Danuta Rość
  Journal of Diabetes and its Complications.2015; 29(5): 686.     CrossRef
• Cerebrovascular diseases: perspectives of pathogenetic metabolic haemangiocorrective treatment
  M. M. Tanashyan, O. V. Lagoda, K. V. Antonova
  Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova.2015; 115(9): 70.     CrossRef
• Letter: Clinical Marker of Platelet Hyperreactivity in Diabetes Mellitus (Diabetes Metab J2013;37:423-8)
  Cengiz Beyan, Esin Beyan
  Diabetes & Metabolism Journal.2014; 38(2): 158.     CrossRef
• Response: Clinical Marker of Platelet Hyperreactivity in Diabetes Mellitus (Diabetes Metab J2013;37:423-8)
  Jin Hwa Kim, Hak Yeon Bae, Sang Yong Kim
  Diabetes & Metabolism Journal.2014; 38(2): 160.     CrossRef

Diabetic vascular complications are among the leading causes of morbidity and mortality in diabetic patients. In the past, many studies have focused on the mechanisms of hyperglycemia-induced chronic vascular complications via the formation of toxic metabolites such as oxidative stress, advanced glycosylated end products, persistent activation of protein kinase C, and increased sorbitol concentrations. However, vascular complications result from imbalances caused by increases in systemic toxic metabolites, such as those that occur under conditions of hyperglycemia and dyslipidemia, and by reductions in endogenous protective factors such as insulin, vascular endothelial growth factor, and platelet derived growth factor. This review outlines some of the evidence supporting the importance of enhancing endogenous regenerative factors.

Citations

Citations to this article as recorded by  

• Role of platelet-derived growth factor c on endothelial dysfunction in cardiovascular diseases
  Adriana Grismaldo, Luis Sobrevia, Ludis Morales
  Biochimica et Biophysica Acta (BBA) - General Subjects.2022; 1866(10): 130188.     CrossRef
• Ginkgo biloba extracts protect human retinal Müller glial cells from t-BHP induced oxidative damage by activating the AMPK-Nrf2-NQO-1 axis
  Yue Li, Ke Wang, Xue Zhu, Zhengqi Cheng, Ling Zhu, Michael Murray, Fanfan Zhou
  Journal of Pharmacy and Pharmacology.2022;[Epub]     CrossRef
• Organic Isothiocyanates as Hydrogen Sulfide Donors
  Alma Martelli, Valentina Citi, Lara Testai, Simone Brogi, Vincenzo Calderone
  Antioxidants & Redox Signaling.2020; 32(2): 110.     CrossRef
• PGC‐1α, a potential therapeutic target against kidney aging
  Gayoung Lee, Md Jamal Uddin, Yoojeong Kim, Minji Ko, Inyoung Yu, Hunjoo Ha
  Aging Cell.2019;[Epub]     CrossRef
• Glucometabolic characteristics and higher vascular complication risk in Korean patients with type 2 diabetes with non-albumin proteinuria
  Yongin Cho, Yong-ho Lee, Eun Seok Kang, Bong-soo Cha, Byung-wan Lee
  Journal of Diabetes and its Complications.2019; 33(8): 585.     CrossRef
• Ameliorative effects of taurine against diabetes: a review
  Inam-u-llah, Fengyuan Piao, Rana Muhammad Aadil, Raheel Suleman, Kaixin Li, Mengren Zhang, Pingan Wu, Muhammad Shahbaz, Zulfiqar Ahmed
  Amino Acids.2018; 50(5): 487.     CrossRef
• Notoginsenoside Fc attenuates high glucose-induced vascular endothelial cell injury via upregulation of PPAR-γ in diabetic Sprague–Dawley rats
  Jingjing Liu, Chunyu Jiang, Xu Ma, Jianbo Wang
  Vascular Pharmacology.2018; 109: 27.     CrossRef
• Grape seed proanthocyanidin extract protects the retina against early diabetic injury by activating the Nrf2 pathway
  YAN SUN, CAIMEI XIU, WEI LIU, YUAN TAO, JIANRONG WANG, YI QU
  Experimental and Therapeutic Medicine.2016; 11(4): 1253.     CrossRef
• Hydrogen peroxide prevents vascular calcification induced ROS production by regulating Nrf-2 pathway
  Wensong Zhang, Yi Li, Hanlu Ding, Yaqin Du, Li Wang
  Renal Failure.2016; 38(7): 1099.     CrossRef
• TNFSF15 Inhibits Blood Retinal Barrier Breakdown Induced by Diabetes
  Feng Jiang, Qingzhong Chen, Liming Huang, Ying Wang, Zhuhong Zhang, Xiangda Meng, Yuanyuan Liu, Chunjie Mao, Fang Zheng, Jingkai Zhang, Hua Yan
  International Journal of Molecular Sciences.2016; 17(5): 615.     CrossRef
• Effect of Triflusal on Primary Vascular Dysregulation Compared with Aspirin: A Double-Blind, Randomized, Crossover Trial
  Sanghoon Shin, Kwang-Joon Kim, In-Jeong Cho, Geu-Ru Hong, Yangsoo Jang, Namsik Chung, Young Min Rah, Hyuk-Jae Chang
  Yonsei Medical Journal.2015; 56(5): 1227.     CrossRef
• NRF2 plays a protective role in diabetic retinopathy in mice
  Zhenhua Xu, Yanhong Wei, Junsong Gong, Hongkwan Cho, James K. Park, Ee-Rah Sung, Hu Huang, Lijuan Wu, Charles Eberhart, James T. Handa, Yunpeng Du, Timothy S. Kern, Rajesh Thimmulappa, Alistair J. Barber, Shyam Biswal, Elia J. Duh
  Diabetologia.2014; 57(1): 204.     CrossRef
• Inhibition of JNK by compound C66 prevents pathological changes of the aorta in STZ‐induced diabetes
  Yucheng Liu, Yonggang Wang, Xiao Miao, Shanshan Zhou, Yi Tan, Guang Liang, Yang Zheng, Quan Liu, Jian Sun, Lu Cai
  Journal of Cellular and Molecular Medicine.2014; 18(6): 1203.     CrossRef
• Sulforaphane Attenuation of Type 2 Diabetes-Induced Aortic Damage Was Associated with the Upregulation of Nrf2 Expression and Function
  Yonggang Wang, Zhiguo Zhang, Wanqing Sun, Yi Tan, Yucheng Liu, Yang Zheng, Quan Liu, Lu Cai, Jian Sun
  Oxidative Medicine and Cellular Longevity.2014; 2014: 1.     CrossRef
• Therapeutic Effect of MG132 on the Aortic Oxidative Damage and Inflammatory Response in OVE26 Type 1 Diabetic Mice
  Xiao Miao, Wenpeng Cui, Weixia Sun, Ying Xin, Bo Wang, Yi Tan, Lu Cai, Lining Miao, Yaowen Fu, Guanfang Su, Yuehui Wang
  Oxidative Medicine and Cellular Longevity.2013; 2013: 1.     CrossRef
• Risk Factors for the Progression of Intima-Media Thickness of Carotid Arteries: A 2-Year Follow-Up Study in Patients with Newly Diagnosed Type 2 Diabetes
  Sang Ouk Chin, Jin Kyung Hwang, Sang Youl Rhee, Suk Chon, You-Cheol Hwang, Seungjoon Oh, Kyu Jeung Ahn, Ho Yeon Chung, Jeong-taek Woo, Sung-Woon Kim, Young Seol Kim, Ja-Heon Kang, In-Kyung Jeong
  Diabetes & Metabolism Journal.2013; 37(5): 365.     CrossRef
• Downregulation of Nrf2 and HO-1 expression contributes to oxidative stress in type 2 diabetes mellitus: A study in Juana Koslay City, San Luis, Argentina
  Susana Siewert, Irma González, Lucas Santillán, Roberto Lucero, Marta S. Ojeda, María S. Gimenez
  Journal of Diabetes Mellitus.2013; 03(02): 71.     CrossRef
• The effect of oral prostaglandin analogue on painful diabetic neuropathy: a double‐blind, randomized, controlled trial
  S. Shin, K. J. Kim, H. ‐J. Chang, B. ‐W. Lee, W. ‐I. Yang, B. ‐S. Cha, D. Choi
  Diabetes, Obesity and Metabolism.2013; 15(2): 185.     CrossRef
• Areca nut procyanidins ameliorate streptozocin-induced hyperglycemia by regulating gluconeogenesis
  Pei-Ling Huang, Chin-Wen Chi, Tsung-Yun Liu
  Food and Chemical Toxicology.2013; 55: 137.     CrossRef
• Serum glycated albumin predicts the progression of carotid arterial atherosclerosis
  Sun Ok Song, Kwang Joon Kim, Byung-Wan Lee, Eun Seok Kang, Bong Soo Cha, Hyun Chul Lee
  Atherosclerosis.2012; 225(2): 450.     CrossRef
• Sulforaphane prevention of diabetes-induced aortic damage was associated with the up-regulation of Nrf2 and its down-stream antioxidants
  Xiao Miao, Yang Bai, Weixia Sun, Wenpeng Cui, Ying Xin, Yuehui Wang, Yi Tan, Lining Miao, Yaowen Fu, Guanfang Su, Lu Cai
  Nutrition & Metabolism.2012;[Epub]     CrossRef
• Association between EPCs count and rate of coronary revascularization in asymptomatic type 2 diabetic patients
  Hyun Min Kim, Kwang Joon Kim, Jae Hoon Moon, Hye-Jeong Lee, Min Kyung Chae, Hyuk-Jae Chang, Eun Seok Kang, Bong Soo Cha, Hyun Chul Lee, Young Jin Kim, Byung-Wan Lee
  Acta Diabetologica.2012; 49(6): 413.     CrossRef
• Taurine ameliorates hyperglycemia and dyslipidemia by reducing insulin resistance and leptin level in Otsuka Long-Evans Tokushima fatty (OLETF) rats with long-term diabetes
  Kyoung Soo Kim, Da Hee Oh, Jung Yeon Kim, Bong Gn Lee, Jeong Soon You, Kyung Ja Chang, Hyunju Chung, Myung Chul Yoo, Hyung-In Yang, Ja-Heon Kang, Yoo Chul Hwang, Kue Jeong Ahn, Ho-Yeon Chung, In-Kyung Jeong
  Experimental & Molecular Medicine.2012; 44(11): 665.     CrossRef
• Inhibition of NF-κB prevents high glucose-induced proliferation and plasminogen activator inhibitor-1 expression in vascular smooth muscle cells
  In-Kyung Jeong, Da Hee Oh, Seung-Joon Park, Ja-Heon Kang, Sunshin Kim, Myung-Shik Lee, Myung-Jun Kim, Yoo-Chul Hwang, Kyu Jeong Ahn, Ho-Yeon Chung, Min-Kyung Chae, Hyung-Joon Yoo
  Experimental and Molecular Medicine.2011; 43(12): 684.     CrossRef